Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Helen E. Heslop, Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi Bin Chen, Amy E. DeZern, Mary Eapen, Mehdi Hamadani, Betty K. Hamilton, Parameswaran Hari, Richard J. Jones, Brent R. Logan, Leslie S. Kean, Eric S. Leifer, Frederick L. Locke, Richard T. Maziarz, Eneida R. Nemecek, Marcelo Pasquini, Rachel Phelan, Marcie L. RichesBronwen E. Shaw, Mark C. Walters, Amy Foley, Steven M. Devine, Mary M. Horowitz

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.

Original languageEnglish (US)
Pages (from-to)885-907
Number of pages23
JournalTransplantation and Cellular Therapy
Volume27
Issue number11
DOIs
StatePublished - Nov 2021

Keywords

  • BMT
  • Cell Therapy
  • Clinical Trial
  • Humans
  • Bone Marrow Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Transplants
  • Clinical Trials as Topic

ASJC Scopus subject areas

  • Transplantation
  • General Medicine
  • Molecular Medicine
  • Hematology
  • Immunology and Allergy
  • Cell Biology

Fingerprint

Dive into the research topics of 'Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year'. Together they form a unique fingerprint.

Cite this